Department of Physiology, Faculty of Medicine, Center for the Study of Pain, University of Toronto, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada.
Science. 2010 Dec 3;330(6009):1400-4. doi: 10.1126/science.1191792.
Synaptic plasticity is a key mechanism for chronic pain. It occurs at different levels of the central nervous system, including spinal cord and cortex. Studies have mainly focused on signaling proteins that trigger these plastic changes, whereas few have addressed the maintenance of plastic changes related to chronic pain. We found that protein kinase M zeta (PKMζ) maintains pain-induced persistent changes in the mouse anterior cingulate cortex (ACC). Peripheral nerve injury caused activation of PKMζ in the ACC, and inhibiting PKMζ by a selective inhibitor, ζ-pseudosubstrate inhibitory peptide (ZIP), erased synaptic potentiation. Microinjection of ZIP into the ACC blocked behavioral sensitization. These results suggest that PKMζ in the ACC acts to maintain neuropathic pain. PKMζ could thus be a new therapeutic target for treating chronic pain.
突触可塑性是慢性疼痛的关键机制。它发生在中枢神经系统的不同水平,包括脊髓和大脑皮层。研究主要集中在触发这些可塑性变化的信号蛋白上,而很少有研究涉及与慢性疼痛相关的可塑性变化的维持。我们发现蛋白激酶 M ζ(PKMζ)维持着小鼠前扣带皮层(ACC)中疼痛诱导的持续变化。外周神经损伤导致 ACC 中的 PKMζ 激活,而通过选择性抑制剂 ζ-假底物抑制肽(ZIP)抑制 PKMζ 则消除了突触增强。将 ZIP 微注射到 ACC 中可阻断行为敏感化。这些结果表明,ACC 中的 PKMζ 可维持神经性疼痛。因此,PKMζ 可能成为治疗慢性疼痛的新治疗靶点。